{{Rsnum
|rsid=1760944
|Gene=OSGEP
|Chromosome=14
|position=20454990
|Orientation=minus
|GMAF=0.4073
|Gene_s=APEX1,OSGEP
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 16.8 | 47.8 | 35.4
| HCB | 26.3 | 56.2 | 17.5
| JPT | 20.4 | 45.1 | 34.5
| YRI | 8.9 | 30.8 | 60.3
| ASW | 5.3 | 57.9 | 36.8
| CHB | 26.3 | 56.2 | 17.5
| CHD | 31.2 | 57.8 | 11.0
| GIH | 15.8 | 48.5 | 35.6
| LWK | 7.3 | 39.1 | 53.6
| MEX | 20.7 | 62.1 | 17.2
| MKK | 3.8 | 40.4 | 55.8
| TSI | 13.7 | 48.0 | 38.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=19631633
|Title=Haplotype-based case-control study between human apurinic/apyrimidinic endonuclease 1/redox effector factor-1 gene and cerebral infarction
}}

{{PMID Auto
|PMID=20010699
|Title=Haplotype-based case-control study on human apurinic/apyrimidinic endonuclease 1/redox effector factor-1 gene and essential hypertension
}}

{{PMID Auto
|PMID=21615620
|Title=A genetic variation in APE1 is associated with gastric cancer survival in a Chinese population
}}

{{PMID Auto
|PMID=19029194
|Title=Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans.
|OA=1
}}

{{PMID Auto
|PMID=19541747
|Title=Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility.
}}

{{PMID Auto
|PMID=21538578
|Title=Genetic polymorphisms in APE1 are associated with renal cell carcinoma risk in a Chinese population.
}}

{{PMID Auto
|PMID=23505922
|Title=Association of the polymorphism of APE1 gene with the risk of prostate cancer in Chinese Han population
}}

{{PMID Auto
|PMID=24257553
|Title=Apurinic/Apyrimidinic Endonuclease 1 Polymorphisms Are Associated With Ovarian Cancer Susceptibility in a Chinese Population
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}